| Metric | შპს ანშენ ფარმა | შპს Linema Pharm |
|---|---|---|
| Growth | ||
| Revenue | ₾1.8m₾2.2m | ₾3.9m₾1.6m |
| Revenue growth | -15.9% | 139.8% |
| Profitability | ||
| EBITDA | ₾611k₾355k | ₾1.2m₾465k |
| EBITDA margin | 33.4%16.3% | 31.0%28.7% |
| Net profit | ₾520k₾288k | ₾1.2m-₾90k |
| Net margin | 28.4%13.2% | 31.0%-5.5% |
| Balance sheet | ||
| Total assets | ₾2.7m₾2.3m | ₾7.5m₾6.2m |
| Total equity | ₾2.7m₾2.2m | ₾6.4m₾5.4m |
| ROE | 19.2%13.1% | 18.9%-1.6% |